Research Assistantship Opportunity – Graduate Research Assistantships in Research Ethics: The Rotman Institute of Philosophy, Western University
Job category: Graduate fellowship / Fixed term
AOS: Research ethics
AOS categories: Philosophy of Science, Applied Ethics, Biomedical Ethics, Ethics
Workload: Part time
Location: London, Ontario, Canada
Start date: September 2018
Graduate Research Assistantships in Research Ethics at Western University
We are seeking two doctoral students interested in the ethics of pragmatic randomized controlled trials (RCTs) to pursue their graduate education in the Department of Philosophy at Western University. The Graduate Research Assistantships in Research Ethics are research positions that run concurrently with the philosophy graduate programme. Students will be expected to contribute to a Canadian Institutes of Health Research funded project that includes a competitive stipend to supplement the funding package from Western University. The successful candidates will join our diverse research team, comprising philosophers, trialists and biostatisticians from five countries, who are developing guidance for the ethical design and conduct of pragmatic RCTs. Pragmatic RCTs test if an intervention works in real-world conditions and support decision-making by patients, providers and health system managers. A description of the project is available at the Rotman Institute of Philosophy website.
Core members of our research team have worked together for a decade. Previous work explored ethical issues in cluster randomized trials (CRTs). CRTs differ from conventional randomized trials in that intact social units—rather than individuals—are randomly allocated to study interventions. Our research team analyzed the ethical issues in CRTs in a series of articles in the journal Trials. Empirical studies included interviews with trialists, a systematic review of published CRTs and a survey of research ethics committees in three countries. In 2012, we published the world’s first ethical guidelines for CRTs, the Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials. Our trainees have benefitted from mentoring by diverse faculty members in the research team. Our trainees have gone on to research and faculty positions at Harvard University, the University of Oxford and other excellent institutions. Our new project will build and expand upon our previous work and address the clear need for ethics guidance for pragmatic RCTs.
Successful candidates will have a strong background in moral theory or philosophy of science, and will be expected to participate fully in the activities of our interdisciplinary research team. These activities include research on ethical issues specific to pragmatic RCTs, collaborations with scholars from other disciplines, presenting work at conferences, writing academic papers for philosophy and medical journals, and engaging the public through education and social media.
Given the interdisciplinary nature of the project, successful candidates must (1) be able to work within and across disciplinary boundaries, (2) communicate effectively, (3) be highly motivated and (4) demonstrate professionalism. A Master’s degree in applied ethics, bioethics or philosophy of science is preferred, but not required. Accomplished and exceptionally motivated individuals in relevant fields will also receive full consideration. Questions about the research positions may be addressed to Prof. Charles Weijer.
Applicants for the Graduate Research Assistantships in Research Ethics should send a cover letter, CV, university transcripts and writing sample to Prof. Charles Weijer on or before January 7, 2018. Applicants must (1) independently submit all required materials to the philosophy graduate programme by January 7, 2018 and (2) be selected for admission to the graduate program. Click here for more information on graduate studies in philosophy at Western University. Successful applicants for the Graduate Research Assistantships in Research Ethics will be notified in March 2018, and the positions begin in September 2018.
How to apply
Application type: Email
Instructions: Applicants for the Graduate Research Assistantships in Research Ethics should send a cover letter, CV, university transcripts and writing sample to Prof. Charles Weijer on or before January 7, 2018. Applicants must (1) independently submit all required materials to the philosophy graduate programme by January 7, 2018 and (2) be selected for admission to the graduate program.
Email to apply: firstname.lastname@example.org
Hard deadline: January 7, 2018, 11:59pm EST
Contact Web address for more information: www.rotman.uwo.ca/portfolio-items/pragmatic…
Contact name: Prof. Charles Weijer
Contact email: email@example.com
(STAT News) – The hepatitis A outbreak now roiling this well-heeled, coastal city may have had its roots in a baseball game — when the city cleaned up for the 2016 All-Star Game by pushing its homeless out of the touristy areas downtown and into increasingly congested encampments and narrow freeway onramps just east of downtown. The lines of tents stretched for blocks. At the same time, the city was locking and removing bathrooms to help control the rampant drug and prostitution trade they’d spawned. Hepatitis A is transmitted through contact with feces from an infected person, and in close, unsanitary conditions, the highly contagious virus can spread explosively. So it was only a matter of time, experts say, before cases would surge among the homeless.
(Wired) – Now, after more than 20 years of work, one team of doctors and researchers is close to offering patients an implantable artificial kidney, a bionic device that uses the same technology that makes the chips that power your laptop and smartphone. Stacks of carefully designed silicon nanopore filters combine with live kidney cells grown in a bioreactor. The bundle is enclosed in a body-friendly box and connected to a patient’s circulatory system and bladder—no external tubing required.
(BBC) – A father has lost a damages claim against a London IVF clinic after his ex-partner forged his signature to use frozen embryos. The High Court found IVF Hammersmith was not negligent. The couple broke up in 2010 but some months later the woman asked the clinic to implant an embryo, which they had stored. The man, who can only be identified as ARB, said he did not give his consent and was tricked by his former partner.
(Fox News) – Posting videos from the operating room may be a creative way for plastic surgeons to market their skills, but critics say some surgeons seem to place entertainment value ahead of medical ethics. A new paper published in the journal Plastic and Reconstructive Surgery takes aim at surgical staffs who appear to be more interested in singing and dancing in the ER than in treating patients.
(MedPage Today) – Left ventricular assist devices (LVADs) are used increasingly as destination therapy instead of as a temporary bridge until a donor heart becomes available for transplantation. Now patients, their families, and their caregivers are forced to confront the extremely difficult question of when and how to turn off these devices at the end of life. “In the United States, the ethical and legal principles of LVAD deactivation are well-established,” Colleen K. McIlvennan (University of Colorado) and colleagues wrote in the Journal of Cardiac Failure.
(The Conversation) – There have been numerous surveys and opinion polls on public attitudes towards assisted dying in recent years. The British Social Attitudes (BSA) Survey, which has asked this question sequentially since the 1980s, has shown slowly increasing public support. Asked: “Suppose a person has a painful incurable disease. Do you think that doctors should be allowed by law to end the patient’s life, if the patient requests it?” in 1984, 75% of people surveyed agreed. By 1989, 79% of people agreed with the statement, and in 1994 it had gone up to 82%.
(STAT News) – Decades after the U.S. Congress repeatedly reaffirmed its support for publicly funded fetal tissue research, investigators find themselves facing efforts by this same body to prevent this kind of research. At issue is whether fetal tissue research continues to be necessary, whether it has the potential to contribute to new therapies, and whether sufficient safeguards are in place for the research to occur ethically. The answer to each of those is an unequivocal “yes.” Fetal tissue has been essential in research used to develop therapies that have saved millions of lives, and it continues to be necessary for the future of medicine.
(The Guardian) – The credibility of stem cell research is at risk because of charlatans and dodgy clinics peddling unproven cures for diseases, according to a group of eminent scientists in the field. Stem cell research, or regenerative medicine, has great potential and has already delivered some breakthroughs, but its future is threatened by poor science, unrealistic hopes, unclear funding models and unscrupulous private clinics, they say in the Lancet medical journal. A special Lancet commission made up of leading experts has reviewed the progress to date in a field that was once thought to offer answers potentially to all forms of disease and disability.
(GEN) – cientists have developed a gold nanoparticle technology for delivering the CRISPR/Cas9 gene-editing system to cells that, when tested in the mdx mouse model of Duchenne muscular dystrophy (DMD), repaired the faulty DMD gene, leading to improved strength and agility and reduced fibrosis. Professor Niren Murthy, Ph.D., the University of California, Berkeley (UC Berkeley) researcher who led development of the CRISPR-Gold platform, suggested to GEN that human clinical gene-editing trials using the system could feasibly start within the next few years.
(STAT News) – Adults in the United States who are providing long-term care for aging relatives and friends have little training for their stressful roles, but plenty of commitment, according to a poll. The Associated Press-NORC Center for Public Affairs Research survey finds that caregivers don’t just give rides to the doctor and go shopping. Nearly half provide some kind of medical care, from changing bandages (30 percent) to inserting catheters or feeding tubes (6 percent).
(STAT News) – Only about half of the cancer drugs approved by the European Medicines Agency in the last few years were later shown to help patients live longer or improved their lives, a new study says. Scientists in Britain and Latvia analyzed reports from the European regulator on cancer approvals from 2009 to 2013. Many of the approvals were based only on initial measures that suggested the drug might improve health, like tumor shrinkage.
(Scientific American) – The RNAi delivery systems remain highly complex—and the most effective technologies are still protected by patents that make it difficult for startups to get into the field. Safety concerns persist with other RNAi drugs in development: Last year, for instance, Alnylam had to scrap revusiran, one of its most advanced drugs. Rather than alleviating it, the drug exacerbated pain in a rare nerve disease called transthyretin amyloidosis. And several patients died in the clinical trial, though it’s still not clear exactly why. Alnylam’s stock plummeted by half on that news.
(ABC News) – The fledgling field of gene therapy has scored another win: An experimental treatment seemed to help boys with the inherited nerve disease featured in the movie “Lorenzo’s Oil.” Fifteen of the 17 boys treated in a study had no major disability two years later — remarkable for a disease that often causes swift decline and kills within a decade.
(Undark) – We now know that the Holmes opinion was both cruel and false — and is contradicted by a historic marker in Charlottesville, Virginia that has nothing to do with the Civil War, or the soldier-on-horseback monuments that have generated so much controversy recently. This much more obscure marker recalls Buck’s case and declares that she had no “hereditary defects.” Instead, she was the victim of a sham trial that began her trip to the Supreme Court, and provided justification for 60,000 poor or disabled people in 32 states who were sterilized under laws similar to Virginia’s Sterilization Act of 1924, which aimed to prevent people diagnosed with “insanity … idiocy, imbecility, feeble-mindedness or epilepsy” from reproducing.
(Reuters) – A seasonal flu vaccine that would be the first in the world to fight all types of the virus is to be tested in a two-year clinical trial involving more than 2,000 patients by researchers in Oxford. The so-called universal vaccine was developed by Oxford University’s Jenner Institute and Vaccitech, a spin-out biotech company founded by Jenner scientists.
(NPR) – ALD is a genetic brain disorder depicted in the 1992 movie Lorenzo’s Oil, which portrayed a couple whose son became debilitated by the disease. The most serious form of the illness typically strikes boys between the ages of 4 and 10. Most are diagnosed too late for treatment to be successful, and they often die before their 10th birthday. The more De Nies learned about ALD, the more she realized how fortunate the family was to have discovered Gregory’s condition so early. Her son’s blood was tested when he was about 10 months old.
(CNN) – An unusually widespread outbreak of the plague is menacing Madagascar. At least 24 people have died and more than 130 have been infected with plague across the country, according to the World Health Organization. Plague is endemic to the country, but “contrary to past outbreaks, this one is affecting larger urban areas and ports, which increases the risk of person-to-person transmission,” WHO spokesman Tarik Jasarevic said.